Cytek Biosciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Cytek Biosciences, Inc. (CTKB) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents98.72167.30296.60364.62165.23
Short-Term Investments179.1595.1144.550.000.00
Cash & Short-Term Investments277.86262.41341.15364.62165.23
Accounts Receivable60.5956.1250.8829.7618.10
Inventory43.8961.1748.7832.1723.05
Other Current Assets1.943.994.450.710.91
Total Current Assets396.45392.06454.02431.73208.62
Non-Current Assets
Property, Plant & Equipment (Net)28.1329.2627.575.852.14
Long-Term Investments1.600.000.000.000.00
Goodwill16.6616.1810.1410.140.48
Intangible Assets20.1323.084.334.740.27
Other Non-Current Assets4.763.392.961.671.09
Total Non-Current Assets103.05102.4045.0031.570.00
Total Assets499.50494.46519.48463.31219.98
Current Liabilities
Accounts Payable5.533.034.813.032.94
Short-Term Debt4.660.570.580.000.00
Current Portion of Long-Term Debt0.500.570.580.000.00
Accrued Liabilities6.6818.9920.426.138.65
Deferred Revenue26.6124.1314.548.104.29
Other Current Liabilities2.115.765.522.927.42
Total Current Liabilities67.6656.2349.0433.1826.54
Non-Current Liabilities
Long-Term Debt1.051.652.270.000.00
Other Non-Current Liabilities11.4018.9117.1814.9511.70
Total Non-Current Liabilities36.1045.1744.8924.740.00
Total Liabilities103.76101.3993.9357.9241.69
Stockholders' Equity
Common Stock0.130.130.140.130.02
Retained Earnings-35.20-29.18-17.03-19.61-22.61
Accumulated Other Comprehensive Income0.02-1.28-0.700.900.07
Additional Paid-in Capital430.79423.39442.89423.630.00
Minority Interest0.000.000.250.340.00
Shares Outstanding129.21130.71135.37133.750.00
Total Stockholders' Equity395.74393.06425.55405.04178.29
Total Liabilities & Equity499.50494.46519.48463.310.00